Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii
Open Access
- 10 June 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (24)
Abstract
The OXA β-lactamases in Acinetobacter baumannii represent a primary mechanism for resistance to the carbapenems, a class of antibiotics that represent a last line for treatment. In a screen of an U.S. Food and Drug Administration (FDA)-approved drug library, we identified fendiline, a calcium channel blocker, had significantly more antimicrobial activity against OXA-23 expressing cells. Genetic and proteomic studies revealed that fendiline inhibited the essential lipoprotein trafficking pathway (Lol) in both A. baumannii (LolFD) and Escherichia coli (LolCDE). We demonstrate that OXA-23 is an outer membrane lipoprotein and its overexpression resulted in increased lethality in lolFD- depleted A. baumannii . Our results indicate that overexpression of the OXA-23 β-lactamase in A. baumannii stresses normal lipoprotein trafficking, which makes these cells more susceptible to fendiline. Overall, our data reveal a link between carbapenem resistance and the Lol pathway, which can be leveraged for new drug development.Keywords
Funding Information
- HHS | NIH (AI72219)
- HHS | NIH (AI72219)
- U.S. Department of Veterans Affairs (I01BX001725)
- U.S. Department of Veterans Affairs (IK6BX004470)
- U.S. Department of Veterans Affairs (IK2BX005911)
This publication has 48 references indexed in Scilit:
- In Situ Biofilm Affinity-Based Protein Profiling Identifies the Streptococcal Hydrolase GbpB as the Target of a Carolacton-Inspired Chemical ProbeJournal of the American Chemical Society, 2024
- Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)Journal of Global Antimicrobial Resistance, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Broad Spectrum Antibiotic Xanthocillin X Effectively Kills Acinetobacter baumannii via Dysregulation of Heme BiosynthesisACS Central Science, 2021
- The Science of Antibiotic DiscoveryCell, 2020
- A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysisThe Journal of Pathology, 2020
- Molecular Surveillance of Multidrug-Resistant Acinetobacter baumanniiCurrent Microbiology, 2019
- A Brief History of Protein Sorting PredictionThe Protein Journal, 2019
- LPS Quantitation Procedures2014
- An alternate pathway for the processing of the prolipoprotein signal peptide in Escherichia coli.Journal of Biological Chemistry, 1985